SIGA TECHNOLOGIES INC

Listed Company
SIGACIK 0001010086NasdaqAcceleratedPharmaceutical PreparationsDelawareFY ends Dec 31
Period
FY 2025
Revenue
$94.57M
Net Income
$23.28M
Total Assets
$219.47M
Equity
$198.82M
Shares Out
71.72M
Op. Cash Flow
$43.47M
SIGA$3.44−48.66% · past yearDBEQ Basic
Daily closing prices

Business

SIGA Technologies is a commercial-stage pharmaceutical company that develops and sells TPOXX® (tecovirimat), an antiviral drug for treating human smallpox, mpox, cowpox, and vaccinia complications. The company sells oral and intravenous formulations of TPOXX® primarily to the U.S. Government through the Strategic National Stockpile and to international governments, with regulatory approvals from the FDA, EMA, MHRA, PMDA, and Health Canada. SIGA does not manufacture TPOXX® itself but relies on contract manufacturing organizations for production and outsources all manufacturing operations while retaining intellectual property, regulatory, and supply rights.

Summary from 10-K filed 2026-03-10

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts
ConceptTrend
FY 2025
2025-12-31
FY 2024
2024-12-31
FY 2023
2023-12-31
FY 2022
2022-12-31
FY 2021
2021-12-31
RevenueFromContractWithCustomerExcludingAssessedTax95139140111134
CostOfGoodsAndServicesSold3031181017
SellingGeneralAndAdministrativeExpense2125223518
ResearchAndDevelopmentExpense2012162310
CostsAndExpenses7169566845
OperatingIncomeLoss2470844389
NonoperatingIncomeExpense7641101,172
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest3076884489
IncomeTaxExpenseBenefit−7−17−20−10−20
NetIncomeLoss2359683469
EarningsPerShareBasic0.330.830.950.460.92
EarningsPerShareDiluted0.320.820.950.460.91
WeightedAverageNumberOfSharesOutstandingBasic7271717375
WeightedAverageNumberOfDilutedSharesOutstanding7272727476

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is SIGA TECHNOLOGIES INC's CIK number?

SIGA TECHNOLOGIES INC's SEC CIK number is 0001010086 (1010086). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find SIGA TECHNOLOGIES INC's SEC filings?

All of SIGA TECHNOLOGIES INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did SIGA TECHNOLOGIES INC last report earnings?

SIGA TECHNOLOGIES INC (SIGA) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001140361-26-019538). This is SIGA TECHNOLOGIES INC's most recent earnings filing of record — not a forecast of its next earnings date.

What is SIGA TECHNOLOGIES INC's most recent earnings 8-K?

SIGA TECHNOLOGIES INC's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001140361-26-019538. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View SIGA TECHNOLOGIES INC's latest earnings 8-K →
Look up any company's CIK number →